← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1973Last known activity
May 1, 2025
Timeline
1940s
- Jan 1, 1946
Oklahoma Medical Research Foundation— Founded
Drugs by trial phase (23 distinct, 19 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Cardiovascular Diseases
- Chickenpox
- Chronic Disease
- Coronary Disease
- Coronavirus Infections
- Heart Diseases
- Herpes Zoster
- Hypersensitivity
- Insulin Resistance
- Ischemia
- Lupus Erythematosus, Systemic
- Myocardial Ischemia
- Severe Acute Respiratory Syndrome
- Sjogren's Syndrome
- Syndrome
- Synovitis
- Varicella Zoster Virus Infection
- Virus Diseases
Recent trials (32)
- NCT06828159CollaboratorN/AMay 1, 2025
- NCT05483465CollaboratorPhase 4Dec 1, 2022
- NCT05000216Study chairPhase 2Aug 13, 2021
- NCT04726553Lead sponsorEarly Phase 1Jan 20, 2021
- NCT04523246CollaboratorEarly Phase 1Sep 1, 2020
- NCT04264897Lead sponsorPhase 3Mar 1, 2020
- NCT04264897Reponsible party - principal investigatorPhase 3Mar 1, 2020
- NCT04264897Overall official - principal investigatorPhase 3Mar 1, 2020
- NCT03355482Lead sponsorPhase 2Apr 10, 2017
- NCT02270970Overall official - principal investigatorPhase 4Oct 1, 2014
- NCT02270970Lead sponsorPhase 4Oct 1, 2014
- NCT02270957Reponsible party - principal investigatorPhase 2Jan 1, 2014
- NCT02270957Study directorPhase 2Jan 1, 2014
- NCT02270957Lead sponsorPhase 2Jan 1, 2014
- NCT01946880Study chairPhase 2Nov 1, 2013
Details
- Founded
- Oklahoma City, OK, US Jan 1, 1946
- Last known activity
- May 1, 2025